(Q33540916)

27 July 2017

1 reference

title

Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia (English)

1 reference

hereditary spastic paraplegia

27 July 2017

0 references

1 reference

1 reference

1 reference

1 reference

A H Schapira

1

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Biochimica et Biophysica Acta

27 July 2017

published in

1 reference

27 July 2017

volume

1410

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

159-170

1 reference

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Parkinson's disease in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Parkinson's disease in a nationwide twin cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Parkinson's disease in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

7 January 2021

A parkinsonian kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

A large kindred with autosomal dominant Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Autosomal dominant Lewy body parkinsonism in a four-generation family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Maternal inheritance in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial respiratory chain function in multiple system atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial involvement in Parkinson's disease: the controversy continues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Platelets as a model for neurones?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

The clinical features of mitochondrial myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Point mutations of mitochondrial genome in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial DNA in postmortem brain from patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Absence of the mitochondrial A7237T mutation in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Origin and functional consequences of the complex I defect in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Nuclear membrane indentations in Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Neuropathological changes of the nucleus accumbens in Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial defect in Huntington's disease caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Requirement for superoxide in excitotoxic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Complex I defect in muscle from patients with Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial function in Huntington's disease: clues for pathogenesis and prospects for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Pure hereditary spastic paraplegia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Developmental trends of sleep-disordered breathing in Prader-Willi syndrome: the role of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Frataxin gene of Friedreich's ataxia is targeted to mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Temperature sensitive pet mutants in yeast Saccharomyces cerevisiae that lose mitochondrial RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Heat shock protein HSP60 can alleviate the phenotype of mitochondrial RNA-deficient temperature-sensitive mna2 pet mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Glucose metabolism alterations in Friedreich's ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Pyruvate oxidation in neuromuscular diseases. Evidence of a genetic defect in two families with the clinical syndrome of Friedreich's ataxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Low Activities of the Pyruvate and Oxoglutarate Dehydrogenase Complexes in Five Patients with Friedreich's Ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

The Quebec Cooperative Study of Friedreich's Ataxia: 1974-1984--10 years of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Clinical and genetic abnormalities in patients with Friedreich's ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

Studies on brain biopsies of patients with Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900164-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2728(98)00164-9

1 reference

27 July 2017

1 reference